ADIPONECTIN: BIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS
Issue:
8
Year:
2016
The paper discusses the current views of the biological effects of adiponectin and considers its role in the development of insulin resistance, atherosclerosis, and cardiovascular diseases.
Keywords:
endocrinology
adiponectin
insulin resistance
type 2 diabetes mellitus
atherosclerosis
cardiovascular diseases
References:
- Dedov I.I.Problema ozhirenija: ot sindroma k zabolevaniju // Ozhirenie i metabolizm. – 2006; 1 (6): 2–4.
- Profilaktika saharnogo diabeta. Doklad VOZ. Per. s angl. / M.: Meditsina, 1995; 136 s. (Serija tehnicheskih dokladov VOZ; 844).
- Buharova G.P., Romantsova T.I. Rasprostranennost' izbytochnogo vesa i ozhirenija po dannym vyborki Moskovskogo regiona // Ozhirenie i metabo-lizm. – 2007; 2: 14–6.
- Després J., Lemieux I. Abdominal obesity and metabolic syndrome // Nature. – 2006; 444: 881–7.
- Scherer P., Williams S., Fogliano M. et al. A novel serum protein similar to C1q, produced exclusively in adipocytes // J. Biol. Chem. – 1995; 270 (45): 26746–9.
- Empana J. Adiponectin isoforms and cardiovascular disease: the epidemiological evidence has just begun // Eur. Heart J. – 2008; 29 (10): 1221–3.
- Cnop M., Havel P., Utzschneider K. et al. Relationship of adiponectin to body fatdistribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex // Diabetologia. – 2003; 46: 459–69.
- Matsuzawa Y., Funahashi T., Kihara S. et al. Adiponectin and Metabolic Syndrome // Arterioscler. Thromb. Vasc. Biol. – 2004; 24: 29–33.
- Seifi S., Nazifi S., Tabandeh M. et al. AdipoR1 and AdipoR2 gene expression are regulated by thyroid hormones in adipose tissue // Mol. Cell. Biochem. – 2013; 377 (1–2): 55–63.
- Kubota N., Yano W., Kubota T. et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake // Cell. Metab. – 2007; 6 (1): 55–68.
- Ceddia R., Somwar R., Maida A. et al. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells // Diabetologia. – 2005; 48 (1): 132–9.
- Majorov A.Ju. Insulinorezistentnost' v patogeneze saharnogo dia beta 2 tipa // Saharnyj diabet. – 2011; 1: 35–43
- Lindsay R., Funahashi T., Hanson R. et al. Adiponectin and development of type 2 diabetes in the Pima Indian population // Lancet. – 2002; 360: 57–8.
- Li S., Shin H., Ding E. et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis // JAMA. – 2009; 302 (2): 179–88.
- Tonjes A., Fasshauer M., Kratzsch J. et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes // PLoS One. – 2010; 5 (11): 13911.
- Wasim H., Al-Daghri N., Chetty R. et al. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians // Cardiovasc. Diabetol. – 2006; 2 (5): 10.
- Verbovoj A.F., Skudaeva E.S., Pashentseva A.V. Urovni rezistina, adi ponektina i insulinorezistentnosti u patsientov s raznoj stepen'ju narushe-nij uglevodnogo obmena // Ozhirenie i metabolizm. – 2011; 3: 57–60.
- Kosygina A.B., Sosunov V.V., Peterkova V.A. i dr. Ekspressija gena adiponektina (ADIPOQ) v podkozhnoj i vistseral'noj zhirovoj tkani i uro-ven' adiponektina syvorotki krovi u detej // Probl. endokrinol. – 2010; 56 (6): 3–8.
- Verbovoj A.F., Verbovaja N.I., Kapralova I.Ju. Adiponektin, leptin i drugie metabolicheskie pokazateli u bol'nyh gipotireozom // Farmateka. – 2014; 10: 67–9.
- Verbovaja N.I., Kapralova I.Ju., Verbovoj A.F. Soderzhanie rezistina i drugih adipokinov u bol'nyh gipotireozom // Ter. arh. – 2014; 10: 33–5.
- Chubrieva S.Ju, Gluhov N.V., Zajchik A.M. Zhirovaja tkan' kak endokrin- nyj reguljator (obzor literatury) // Vestnik Sankt- Peterburgskogo univer-siteta. – 2008; 1: 32–43.
- Cao Y., Tao L., Yuan Y. et al. Endothelial dysfunction in adiponectin deficiency and its mechanisms involved // J. Mol. Cell. Cardiol. – 2009; 46: 413–9.
- Shargorodsky M., Boaz M., Goldberg Y. et al. Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? // Int. J. Obes. (Lond.) – 2009; 33: 553–8.
- Greenstein A., Khavandi K., Withers S. et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients // Circulation. – 2009; 119: 1661–70.
- Shatat I., Freeman K., Vuguin P. et al. Relationship between adiponectin and ambulatory blood pressure in obese adolescents // Pediatr. Res. – 2009; 65: 691–5.
- Osina A.S. Otsenka vzaimosvjazi insulinorezistentnosti i endoteli al'noj disfunktsii u bol'nyh SD 2 tipa. Avtoref. dis. … kand. med. nauk. Samara, 2010; 21 s.
- Antoniades C., Antonopoulos A., Tousoulis D. et al. Adiponectin: from obesity to cardiovascular disease // Obes. Rev. – 2009; 10: 269–79.
- Wannamethee S., Whincup P., Lennon L. et al. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure // Arch. Intern. Med. – 2007; 167: 1510–7.
- Ouedraogo R., Wu X., Xu S. et al. Adiponectin suppression of high-29. glucose- induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway // Diabetes. – 2006; 55 (6): 1840–6.
- Goldstein B., Scalia R., Ma X. Protective vascular and myocardial effects of adiponectin // Nat. Clin. Pract. Cardiovasc. Med. – 2009; 6 (1): 27–35.
- Tao L., Gao E., Jiao X. et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress // Circulation. – 2007; 115 (11): 1408–16.
- Pischon T., Girman C., Hotamisligil G. et al. Plasma adiponectin levels and risk of myocardial infarction in men // JAMA. – 2004; 291 (14): 1730–7.
- Morkovskih N.V. Markery endokrinnoj sistemy i vospalenija kak prognosticheskie faktory riska sosudistyh oslozhnenij pri saharnom dia-bete 2 tipa. Dis. … kand. med. nauk. Samara, 2010; 142 s.
- Shibata R., Ouchi N., Ito M. et al. Adiponectin-mediated modulation of hypertrophic signals in the heart // Nat. Med. – 2004; 10 (12): 1384–9.
- Mitroshina E.V. Kliniko-laboratornye osobennosti ozhirenija, mani festirovavshego v pubertatnyj period u junoshej i muzhchin. Avtoref. dis. … kand. med. nauk. Samara, 2011; 24 s.
- Liao Y., Takashima S., Maeda N. et al. Exacerbation of Heart failure in adiponectin - deficient mice due to impaired regulation of AMPK and glucose metabolism // Cardiovasc. Res. – 2005; 67: 705–13.
- Kapralova I.Ju., Verbovoj A.F., Sharonova L.A. Soderzhanie adipoki-37. nov i pokazateli ehokardiografii u zhenschin s gipotireozom // Klinitsist. – 2014; 2: 17–21.